NCT03931109View on ClinicalTrials.gov

Circulating miRNA in Primary Hyperparathyroidism

CompletedOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

September 7, 2018

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Primary HyperparathyroidismOsteoporosis, Postmenopausal
Trial Locations (1)

19104

Perelman Center for Advanced Medicine/ Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT03931109 - Circulating miRNA in Primary Hyperparathyroidism | Biotech Hunter | Biotech Hunter